(Arbeiten der AG Schmetzer sind fett gedruckt)
Abboud SL, Gerson SL, Berger NA: The effect of tumor necrosis factor on normal human hematopoietic progenitors. Cancer 1987, 60: 2965-2970. Ackerstein A, Kedar E, Slavin S: Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders. Blood 1991, 78: 1212-1215.
Ahmadzahdeh M, Hussain SF, Farber DL: Heterogeneity of the memory CD4 T-cell response: persisting effectors and resting memory T cells. J Immunol 2001, 166 (2): 926-935.
Alcalay M, Zangrilli D, Pandolfi PP, Longo L, Mencarelli A, Giacomucci A, Rocchi M, Biondi A, Rambaldi A, Lo Coco F, et al: Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus. Proc nat Acad Sci 1991; 88: 1977-1981.
Allison JP, Krummel MF: The Yin and Yang of T Cell Costimulation. Science, 1995, 270: 932-933.
Amirghofran Z, Zakerinia M, Shamseddin A: Significant association between expression of the CD11b surface molecule and favorable outcome for patients with acute myeloblastic leukemia. Int J Hematol 2001, 73: 502-506.
Aoyagi M, Furusawa S, Waga K, Tsunogake S, Shishido H: Suppression of normal hematopoiesis in acute leukemia: Effect of leukemic cells on bone marrow stroma cells and hematopoietic progenitor cells. Intern Med 1994; 88: 288-295.
Arai KJ, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T: Cytokines: Coordinators of immune and inflammatory responses. Ann Rev Biochem 1990, 59: 783-836.
Archimbaud E, Thomas X, Campos L, Magaud JP, Dore JF, Fiere D: Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: Relationship within initial characteristics and prognosis. Leukemia 1992; 6: 265-271.
Archimbaud E, Thomas X, Campos L, Magaud JP, Fiere D, Dore JF: Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine activated killer (LAK-cells and its clinical relevance). Leuk Res 1992, 16: 673-680.
Arkin S, Naprstek B, Guarini L, Ferrone S, Lipton JM: Expression of intercellular adhesion molecule-1 (CD54) on hematopoietic progenitors. Blood, 1991, 77: 948-953.
Asano Y, Shibata S, Kobayashi S, Okamura S, Niho Y: Interleukin-10 inhibits the autocrine growth of leukemic blasts from patients with acute myeloblastic leukemia. Int J Hematol 1997, 66: 445-50.
Ashman LK, Roberts MM, Gadd SJ, Cooper SJ, Juttner CA: Expression of a 150-kD cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukemia. Leuk Research 1988, 12: 923-928.
Asosingh K, Remnans W, Van der Gucht K, Foulon W, Schots R, Van Riet I, De Waele M: Circulating CD34+ cells in cord blood and mobilized blood have a different profile of adhesion molecules than bone marrow CD34+ cells. Eur J Haematol 1998, 60: 153-160.
Audet J, Miller CL, Rose-John S, Piret JM, Eaves J: Distinct role of gp130 activation in promoting selfrenewal divisions by mitogenically stimulated murine hematopoietic stem cells. Proc Natl Acad Sci USA 2001, 98: 1757-62.
Auerbach AD: Fanconi anemia and leukemia: tracking the genes. Leukemia 1992, 6 Suppl. 1: 1-4.
Austin H, Delzell E, Cole P: Benzene and leukemia. A review of the literature and a risk assessment. Amer J Epidem 1988, 127: 419-439. Avalos BR: The granulocyte colony stimulating factor receptor and its role in disorders of granulopoiesis. Leuk Lymph 1998, 28: 265-73.
Avraham H, Scadden DT, Chi S, Broudy VC, Zsebo KM, Groopman JE: Interaction of human bone marrow fibroblasts with megakaryocytes: role of c-kit ligand. Blood 1992, 80: 1679-1684.
Baer MR, Stewart CC, Lawrence D, Arthur CD, Byrd CJ, Davey FR, Schiffer CA, Bloomfield CD: Expression of the neural cell adhesion molecule CD56 is associated with short remisson duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood 1997, 4: 1643-1648.
Begemann M (Hrsg.): Akute Leukämien. In: Praktische Hämatologie, Georg-Thieme-Verlag Stuttgart-New York, 11. Aufl.: 183-218.
Bendall LJ, Daniel A, Kortlepel K, Gottlieb DJ: Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp Hematol 1994, 22: 1252- 1260.
Bendall LJ, Kortlepel K, Gottlieb DJ: GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1. Leukemia 1995, 9: 677-684.
Bendall LJ, Kortlepel K, Gottlieb DJ: Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms. Blood 1993, 82: 3125-3132.
Bene MC, Bernier M, Casasnovas RO, Castoldi G, Knapp W, Lanza F, Ludwig WD, Matutes E, Orfao A, Sperling C, van´t Veer MB for the European Group for the Immunological Classification of Leukemias (EGIL): The reliability and specifity of c-kit for the diagnosis of acute myeloid leukemias and
undifferentiated leukemias. Blood, 1998, 92: 596-599.
Leukemias (EGIL): Proposals for the immunological classification of acute leukemias. Leukemia 1995, 9: 1783-1788.
Bennett JM, Catovsky D, Daniel MT et al: Proposals for the classification of the acute leukemias. French-American-British (FAB) co-operative Group. Brit J Haematol 1976, 33: 451-458.
Bennett JM, Catovsky D, Daniel MT et al: Proposed revised criteria for the classification of acute myeloid leukemia. Ann intern Med 1985, 103: 626-629. Bianco P, Robey PG: Marrow stromal cells. J Clin Invest 2000, 105: 1663-1668.
Birg F, Courcoul M, Rosnet O, Bardin F, Pebusque MJ, Marchetto S, Tabilio A, Mannoni P, Birnbaum D: Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 1992, 80: 2584-2593.
Borrow J, Goddard AD, Sheer D, Solomon E: Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990, 249: 1577-1580.
Boyer MW, Waller EK, Bray RA, Unangst T, Johnson TS, Phillips C, Jurickowa I, Winton EF, Yeager AM: Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells. Leukemia 2000, 14: 412-418.
Böyum A: Separation of blood leukocytes, granulocytes and lymphocytes. Tissue Antigens 1984, 4: 269-274.
Bracho F, Krailo MD, Shen V, Bergeron S, Davenport V, Liu-Mares W, Blazar BR, Panoskaltsis-Mortari A, van de Ven C, Secola R, Ames MM, Reid JM, Reaman GH, Cairo MS: A phase I clinical, pharmacological and biological trial of interleukin 6 plus granulocyte colony stimulating factor after ifosfamide, carboplatin and etoposide in children with recurrent/ refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constiutional toxicities. Clin Cancer Res 2001, 7: 58-67.
Bradstock K, Matthews J, Benson E, Page F, Bishop J: Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukemia Study Group. Blood 1994, 84: 1220-1205.
Bradstock KF, Gottlieb DJ: Interactions of acute leukemia cells with the bone marrow microenvironment: Implications for contol of minimal residual disease. Leukemia and Lymphoma 1995, 18: 1-16.
Brasel K, Escobar S, Anderberg R, de Vries P, Gruss HJ, Lyman SD: Expression of the flt3 receptor and its ligand on hematopoietic cell lines. Leukemia 1995, 9: 1212-18.
Brasel K, McKenna HJ, Charrier K, Morris DE, Lyman SD: Hematologic effects of flt3 ligand in vivo in mice. Blood 1996, 88: 2004-2012.
Braun S, Gerhartz W, Schmetzer H: Influence of cytokines and autologous Lymphokine-activated-killer (LAK)-cells on leukemic bone marrow cells and colonies in AML. Acta Haematol 2000b, 105, 209-221.
Braun S, Gerhartz W, Wilmanns W, Schmetzer H: Lymphokine-activated-killer (LAK) cells and cytokines synergize to kill clonal cells in acute myeloid leukemia (AML) in vitro. Haematologia 2000a, 30: 271-288.
Broudy VC, Lin NL, Priestley GV, Nocka K, Wolf NS: Interaction of stem cell factor and its receptor mediates lodgement and acute expansion of hematopoietic cells in the murine spleen. Blood 1996, 88: 75-81.
Broudy VC, Smith FO, Lin N, Zsebo KN, Egrie J, Bernstein ID: Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 1992, 80: 60-67.
Brouwer RE, Hoefnagel J, van der Burg BB, Jedema I, Zwinderman KH, Starrenburg IC, Kluin-Nelemans HC, Barge RM, Willemze R, Falkenburg JH: Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors in acute myeloid leukemia: High CD40 and CD11a expression correlates with poor prognosis. Br J Haematol 2001, 115: 298-308.
Brouwer RE, van der Hoorn M, Kluin-Nelemans HC, van Zelderen-Bhola S, Willemze R, Falkenburg JH: The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB-subclasses. Hum Immunol 2000, 6: 565-574.
Brouwer RE, Zwinderman KH, Kluin-Nelemans HC, van Luxemburg-Heijs SAP, Willemze R, Falkenburg JHF: Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: Implications for adoptive immunotherapy. Exp Haematol 2000, 28: 161-168.
Bruserud O, Halstensen A, Peen E, Solberg CO: Serum levels of adhesion molecules and cytokines in acute leukemia. Leuk Lymph 1996, 23: 423-430. Bruserud O, Pawelec G: Human T-lymphocyte activation in the presence of acute myelogenous leukemia blasts; studies of normal polyclonal T cells and Tlymphocytes clones derived early after allogeneic bone marrow transplantation. Cancer Immunol Immunother 1996, 42: 133-140.
Bruserud O, Ulvestad E: Expression and release of adhesion molecules by human acute myelogenous leukemia blasts. Leuk Res 1999, 23: 149-157. Bruserud O: Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies. Leukemia 1999, 13: 1175-1187.
Büchner T, Hiddemann W, Wormann B, Rottmann R, Zuhlsdorf M, Maschmeyer G, Ludwig WD, Sauerland MC, Frisch J, Schulz G: GM-CSF multiple course priming and long term administration in newly diagnosed AML: hematologic and therapeutic effects. Blood 1994, 84 Suppl. 1 (Abstract): 96. Büchner T, Urbanitz D, Hiddemann W, Rühl H, Ludwig W, Fischer J, Aul HC, Vaupel HA, Kuse R, Zeile G: Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group. J Clin Oncol 1985, 3: 1583-1589.
Büchner T: Akute myeloische Leukämie (AML) in Hämatologie-Onkologie; Hrsg: von Ostendorf PC, Seeber S; Urban und Schwarzenberg, München, 1997: 463- 474.
Budel LM, Touw IP, Delwel R, Clark SC, Lowenberg B: Interleukin-3 and granulocyte-monocyte-colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood 1989; 74: 565-571.
Budel LM, Touw IP, Delwel T, Lowenberg B: Granulocyte-colony-stimulating-factor-receptors in human acute myelocytic leukemia. Blood 1989, 74: 2668- 2673.
Burn P, Kupfer A, Singer SJ: Dynamic membrane-cytoskeletal interactions: specific association of integrin and talin arises in vivo after phorbol ester treatment. Proc Natl Acad Sci USA 1988, 85: 497-501.
Byrd JC, Edenfield WJ, Shields DS, Dawson NA: Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: A clinical review. J Clin Oncol 1995, 13: 1800-1816.
Byrd, JC, Dodge RK, Carrol A, Baer MR, Edwards C, Stamberg J, Qumisyeh M, Moore JO, Mayer RJ, Davey F, Schiffer CA, Bloomfield CD: Patients with t(8;21) (q22;q22) and acute myeloid leukemia have a superior failure-free and overall survival when repetitive cycles of high dose cytarabine are administered. J Clin Oncol 1999, 17: 3767-3775.
Caceres-Cortes J, Rajotte D, Dumouchel J, Haddad P, Hoang J: Produkt of the steel locus suppresses apoptosis in hematopoietic cells. Comparison with pathways activated by granulocyte macrophage colony stimulating factor. J Biol Chem 1994, 269: 12084-12091.
Cairo MS, Suen Y, Sender L, Gillan ER, Ho W, Plunkett JM, van de Ven C: Circulating granulocyte colony stimulation factor (G-CSF) levels after allogeneic and autologous bone marrow transplantation: endogenous G-CSF production correlates with myeloid engraftment Blood 1992, 79: 1869-1873.
Callea V, Morabito F, Martino B, Stelitano C, Oliva B, Nobile F: Diagnostic and prognostic relevance of the immunophenotype in acute myelocytic leukemia. Tumori 1991, 77: 28-31.
Campana D, Ching Hon P: Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood 1995, 85: 1416-1434.
Campana D, Coustan-Smith E: Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry 1999, 38: 139-52.
Campbell AD, Long MW, Wicha MS: Haemonectin, a bone marrow adhesion protein specific for cells of granulocytic lineage. Nature 1987; 329: 744-746. Cannistra SA, Groshek P, Griffin JD: Granulocyte-macrophage-colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in the myeloid blast crisis phase of chronic myeloid leukemia. Leukemia 1989, 3: 328-334.
Cannistra SA, Koenigsmann M, DiCarlo J, Groshek P, Griffin JD: Differentiation-associated expression of two functionally distinct classes of granulocyte- macrophage colony-stimulating factor receptors by human myeloid cells. J Biol Chem 1990, 265: 12656-12663.
Carow CE, Levenstein M, Kaufmann SH, Chen J, Amin S, Rockwell P, Witte L, Borowitz MJ, Civin CI, Small D: Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood 1996, 87: 1089-1096.
Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, Willman C, Hurd DD, Bennet JM, Blume KG, Head DR, Wiernik PH: Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998, 339: 1649-56.
Cavenaugh JD, Gordon-Smith EC, Gibson FM, Gordon MY: Acute myeloid leukemia blast cells bind to human endothelium in vitro utilizing E-Selectin and vascular cell adhesion molecule –1 (VCAM-1). Br J Haematol 1993, 85: 285-291.
Cham JY, Watt SM: Adhesion receptors on hematopoietic progenitor cells. Br J Haematol 2001, 112: 541-557.
Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, et al: Report of the National Cancer Institute - sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990, 8: 813-819.
Choudhury AA, Sutaria S, Charron D, Champlin RJ, Claxton DF: Human leukemia derived dendritic cells: ex vivo development of specific antileukemic cytotoxitiy. Crit Rev Immunol 1998, 18: 121-131.
Clark B, Gallagher R, John T, Dexter MT: Cell adhesion in the stromal regulation of haemopoesis. Balliere´s Clin. Haematol. 1992, 5: 619-652. Claxton DF, Lie P, Hsu HB: Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 1994, 83: 1750-1756.
Cohen HJ, Huang ATF: A marker chromosome abnormality: Occurence in chloramphenicol-associated acute leukemia. Arch Intern Med 1973, 132: 440- 443.
Cooper MA, Fehninger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA: Human natural killer cells: a unique innate immunoregulatory role for the CD56 (bright) subset. Blood 2001, 97: 3146-3151.
Cortes JE, Kantarjian HM, O´Brian S, Giles F, Keating MJ, Freireich EJ, Estey EH: A pilot study of interleukin-2 for adult with acute myelogenous leukemia in first complete remission. Cancer 1999, 85: 1506-13.
Coulombel L, Auffrey I, Gaugler MH, Rosemblatt M: Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol 1997, 97: 13-21. Coustan-Smith E, Behm FG, Hurwitz CA, Rivera GK, Campana D: N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia. Leukemia 1993, 7: 853-858.
melphalan and cyclophosphamide treatment for myelomatosis. A report of Medical Research Council´s working party on leukemia in adults. Br J Cancer 1987, 55: 523-529.
D´Souza SE, Ginsberg MH, Plow EF: Arginyl-glyciyl-aspartic acid (RGD): a cell adhesion motif. Trends in Biological Science 1991, 16: 246-250. Danhauser-Riedl S, Ratei R, Hecht K, Schnittger S, Schoch C, Haferlach T, Kolb HJ, Ludwig WD, Hiddemann W: Multiparametric flow cytometry: a promising tool for the detection of minimal residual disease (MRD) in AML? Kongressbeitrag, 1999
Darby SC, Doll R, Smith PG: Long term mortality after a single treatment course with x-ray in patients treated for ancylosing spondylitis. Brit J Cancer 1987, 55: 179-190.
De Gentile A, Toubert ME, Dubois C, Krawice I, Schlageter MH, Balitrand N, Cataigne S, Degos L, Rain JD, Najean Y: Induction of high-affinity GM-CSF receptors during all-trans retinoic acid treatment of acute promyelocytic leukemia. Leukemia 1994, 8: 1758-1762.
De Waele M, Renmans W, Jochmans K, Schots R, Lacor P, Trullemanns F, Otten J, Balduck N, van der Gucht K, van Camp B, van Riet I: Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts. Eur J Haematol 1999, 63: 192- 201.
De Waele M, Renmans W, Van der Gucht K, Jochams K, Schots R, Otten J, Trullemas F, Lacor P, van Riet I: Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts. Eur J Haematol 2001, 66: 178-87.
Dehmel U, Zaborski M, Meierhoff G, Rosnet O, Birnbaum D, Ludwig WD, Quentmeier H, Drexler HG: Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells. Leukemia 1996, 10: 261-270.
Dekker AW, Elderson A, Punt K, Sixma JJ: Meningeal involvement in patients with acute nonlymphocytic leukemia. Cancer 1985, 56: 2078-2082. Demetri G, Griffin JD: Granulocyte colony stimulating factor and its receptor. Blood 1991, 78: 2791-2708.
Denkers IAM, De Jong-De Boer TJ, Beelen RHJ, Ossenkoppele GJ, Nauta JJP, Langenhuijsen MMAC: Adhesive capacity of human long term bone marrow cultures from normals and patients with acute myeloid leukemia: The influence of adhesion molecules. Leuk Res 1993, 17: 255-261.
Denkers IAM, De Jong-De Boer TJM, Beeline RHJ, Ossenkoppele GJ, Langenhuijsen MMAC: VLA molecule expression may be involved in the release of acute myeloid leukemic cells from the bone marrow. Leuk Res 1992; 16: 469-474.
Dercksen MW, Gerritsen WR, Rodenhuis S, Dirkson MKA, Slaper-Cortenbach ICM, Schaasberg WP, Pinedo HM, von dem Borne AEG, van der Schoot CE: Expression of adhesion molecules: CD34+ L-Selectin +cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood 1995, 85: 3313 -3319.
Dercksen MW, Rodenhuis S, Dirkson MK, Schaasberg WP, Baars JW, van der Wall E, Slaper-Cortenbach IC, Pinedo HM, Von dem Borne AE, van der Schoot CE, et al: Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral blood stem cell transplantation. J Clin Oncol 1995, 13: 1922- 1932.
Di Noto R, Lo Pardo C, Schiavone EM, Ferrara F, Manzo C, Vacca C, Del Vecchio L: All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma 1996, 21: 201-209.
Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L: Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. Leukemia 1994, 8: 1900-1905.
Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia AJ, Hibbs ML, Springer TA: ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 1990, 111: 3129-3139.
Dowding C, Guo AP, Osterholz J, Siczkowski M, Goldmann J, Gordon M: Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood 1991, 78: 499-505.
Drexler HG: Expression of FLT3 receptor and response to FLT3-ligand by leukemic cells. Leukemia 1996, 10: 588-599.
Dustin ML, Springer TA: T-cell receptor cross-linking transiently stimulates adhesive-ness through LFA-1. Nature 1989, 341: 619-624. Eder M, Geissler G, Ganser A: IL-3 in the clinic. Stem Cells 1997, 15: 327-333.
El-Deiry WS: Role of oncogenes in resitance and killing by cancer therapeutic agents in: Cancer biology Hrsg: S. Markowitz, Current opinion in Oncology 1997, 9: 79-87.
Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA- 4 at a site distinct from the VLA4/fibronectin binding site. Cel 1990, 60: 577-584.
Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H: Identification of breakpoints in t(8;21) AML and isolation of a fusion transcript with similarity to Drosphila segmentation gene runt. Blood 1992, 80: 1825-1831.
Escribano L, Oqueteau M, Almeida J, Orfao A, San Miguel JF: Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymph 1998, 30: 459-466.
Estey EH, Thall PF, Pierce S, Cortes J, Beran M, Kantarjian H, Keating M, Andreeff M, Freireich E: Randomized phase II study of fludadarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and